Exploiting HIV-1 protease and reverse transcriptase cross-resistance information for improved drug resistance prediction by means of multi-label classification

被引：0
|
作者：
Mona Riemenschneider
Robin Senge
Ursula Neumann
Eyke Hüllermeier
Dominik Heider
机构：
[1] Straubing Center of Science,Department of Bioinformatics
[2] University of Paderborn,Department of Computer Science
[3] Technische Universität München,Wissenschaftszentrum Weihenstephan
[4] University of Applied Science Weihenstephan-Triesdorf,undefined
来源：
BioData Mining | / 9卷
关键词：
Infectious diseases; Machine learning; Retrovirus; HIV therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Genetic Diversity and Drug Resistance Mutations in Reverse Transcriptase and Protease Genes of HIV-1 Isolates from Southwestern Siberia
    Rudometova, Nadezhda B.
    Shcherbakova, Nadezhda S.
    Shcherbakov, Dmitry N.
    Mishenova, Elena V.
    Delgado, Elena
    Ilyichev, Alexander A.
    Karpenko, Larisa I.
    Thomson, Michael M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (09) : 716 - 723
  • [32] HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms
    Ravela, J
    Betts, BJ
    Brun-Vézinet, F
    Vandamme, AM
    Descamps, T
    Van Laethem, K
    Smith, K
    Schapiro, JM
    Winslow, DL
    Reid, C
    Shafer, RW
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (01) : 8 - 14
  • [33] Improving fold resistance prediction of HIV-1 against protease and reverse transcriptase inhibitors using artificial neural networks
    Amamuddy, Olivier Sheik
    Bishop, Nigel T.
    Bishop, Ozlem Tastan
    BMC BIOINFORMATICS, 2017, 18
  • [34] Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy
    Santoro, Maria Mercedes
    Svicher, Valentina
    Gori, Caterina
    Zaccarelli, Mauro
    Tozzi, Valerio
    Forbici, Federica
    d'Arrigo, Roberta
    Trotta, Maria Paola
    Bellocchi, Maria Concetta
    Visco-Comandini, Ubaldo
    Cenci, Alessandra
    Bertoli, Ada
    Narciso, Pasquale
    Antinori, Andrea
    Perno, Carlo Federico
    Ceccherini-Silberstein, Francesca
    NEW MICROBIOLOGICA, 2006, 29 (02): : 89 - 100
  • [35] Insertions and deletions in HIV-1 reverse transcriptase:: Consequences for drug resistance and viral fitness
    Menendez-Arias, Luis
    Matamoros, Tania
    Cases-Gonzalez, Clara E.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (15) : 1811 - 1825
  • [36] Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance
    Neogi, Ujjwal
    Shet, Anita
    Shamsundar, Ranjani
    Ekstrand, Maria L.
    AIDS, 2011, 25 (08) : 1123 - 1126
  • [37] Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase Inhibitors
    Asahchop, Eugene L.
    Wainberg, Mark A.
    Sloan, Richard D.
    Tremblay, Cecile L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (10) : 5000 - 5008
  • [38] No increase in protease resistance and a decrease in reverse transcriptase resistance mutations in primary HIV-1 infection: 1992-2001
    Ammaranond, P
    Cunningham, P
    Oelrichs, R
    Suzuki, K
    Harris, C
    Leas, L
    Grulich, A
    Cooper, DA
    Kelleher, AD
    AIDS, 2003, 17 (02) : 264 - 267
  • [39] Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistance
    Su, Chinh Tran-To
    Ling, Wei-Li
    Lua, Wai-Heng
    Haw, Yu-Xuan
    Gan, Samuel Ken-En
    BMC BIOINFORMATICS, 2016, 17
  • [40] Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistance
    Chinh Tran-To Su
    Wei-Li Ling
    Wai-Heng Lua
    Yu-Xuan Haw
    Samuel Ken-En Gan
    BMC Bioinformatics, 17
12345